Vivos Therapeutics (VVOS) Current Deferred Revenue (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Current Deferred Revenue of $495000.0 for Q1 2026, down 16.67% year-over-year from $594000.0 in Q1 2025, and up 3.34% quarter-over-quarter from $479000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Current Deferred Revenue (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Current Deferred Revenue for 8 consecutive years, with $495000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 16.67% year-over-year to $495000.0; the TTM figure through Mar 2026 stood at $495000.0 (down 16.67% YoY), while the FY2025 annual figure was $479000.0, down 51.76% from the prior year.
- Current Deferred Revenue advanced to $495000.0 in Q1 2026 per VVOS's latest filing, from $479000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.0 million in Q4 2022 and bottomed at $479000.0 in Q4 2025.
- Historically, Current Deferred Revenue has averaged $1.8 million across 5 years, with a median of $2.2 million in 2022.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue soared 34.06% — and 2025, when it tumbled 79.73%.
- Vivos Therapeutics' Current Deferred Revenue stood at $3.0 million in 2022, then dropped by 20.11% to $2.4 million in 2023, then tumbled by 59.09% to $993000.0 in 2024, then sank by 51.76% to $479000.0 in 2025, then climbed by 3.34% to $495000.0 in 2026.
- Business Quant data shows VVOS's Current Deferred Revenue at $495000.0 in Q1 2026, $479000.0 in Q4 2025, and $537000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 537,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 594,000.00 |
| Dec 31, 2024 | 993,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 2.90 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 3.70 Mn |
| Jun 30, 2021 | 4.12 Mn |